Simpson EL, Silverberg J, Nosbaum A, Winthrop K, Guttman-Yassky E, Hoffmeister KM, Egeberg A, Valdez H, Fan H, Farooqui SA, Chan GL, Alderfer J, Romero W, Johnson S. Safety of Abrocitinib in 3582 Patients With Moderate-to-Severe Atopic Dermatitis With Over 900 Patients Exposed for Almost 2 Years. J of Skin [Internet]. 2023Mar.13 [cited 2024Sep.20];7(2):s150. Available from: https://dermsquared.com/skin/article/view/1989